Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06640920 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants
A Phase 1 study, sponsored by Uniquity One (UNI).
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT06640920 is a Phase 1 study that has completed, run by Uniquity One (UNI). The registered enrollment target is 48 participants.
The verdict
NCT06640920, a Phase 1 study, has completed, sponsored by Uniquity One (UNI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
A Phase 1 Randomized, Double-Blind Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Bioavailability of NSI-8226 in Healthy Participants.
Interventions
- BIOLOGICAL Cohort A
- BIOLOGICAL Cohort B
- BIOLOGICAL Cohort C
- BIOLOGICAL Cohort D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-04-29 |
| Est. Completion | 2024-10-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06640920
The ClinicalTrials.gov registry entry for NCT06640920 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Uniquity One (UNI), which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cohort A is the first listed.
NCT06640920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06640920 about?
NCT06640920 is a clinical study titled "A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants". A Phase 1 Randomized, Double-Blind Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Bioavailability of NSI-8226 in Healthy Participants.
What is the current status of trial NCT06640920?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2024-04-29. Estimated completion is 2024-10-29.
What interventions are being tested in trial NCT06640920?
The interventions under investigation include: Cohort A (BIOLOGICAL), Cohort B (BIOLOGICAL), Cohort C (BIOLOGICAL), Cohort D (BIOLOGICAL).
Who is sponsoring clinical trial NCT06640920?
This trial is sponsored by Uniquity One (UNI), which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.